Although the precise mechanisms by which the Her2/neu pathway regulates breast cancer invasion and metastasis are not yet fully understood, it has been suggested that multiple signaling pathways, including ERK1/2 and p38, act as the downstream effectors to promote the invasive potential of these breast cancer cells [15]. The gene discussed is ERBB2; the disease is breast carcinoma.